Revolutionizing microorganism analysis

Microbiology and Diagnostics

Bruker’s broad range of specialized technologies sheds light on the microbial world

The world of microorganisms

The number and diversity of microorganisms infecting humans and animals are ever increasing. Understanding how microbes cause disease and evade treatment is crucial for the protection of global public health. Bruker supports researchers and healthcare providers in the rapid identification and analysis of microorganisms. Our intuitive, robust instrumentation and molecular diagnostics assays meet the needs of both clinical microbiologists and those in industrial and applied microbiology.



Customer information with regards to COVID-19

What your Bruker Microbiology & Diagnostics Team can do for you during the COVID-19 crisis - On-site service for your system, supply of CARE consumables and digital meetings

COVID-19/SARS-CoV-2 Testing

Identifying infection and differentiating from other respiratory diseases

Antimicrobial susceptibility testing

The MICRONAUT broth microdilution (BMD) product portfolio offers a broad range of antibiotic resistance and specialty antimicrobial susceptibility testing.

Microbial Identification (GP + RUO)

The MALDI Biotyper® is an automated next generation microbial identification system based on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, and has become the method of choice for routine identification in clinical microbiology laboratories worldwide.

Microbial Identification for Clinical Laboratories (IVD-CE)

Unbiased and fast identification of microorganisms down to the species level, revolutionizing the analysis of microorganisms

Microbial Identification for Clinical Laboratories (US-IVD)

A key task in clinical microbiology is unbiased and fast identification of microorganisms down to the species level.

Microbial Strain Typing

Fast, easy and cost-effective strain typing for effective hospital hygiene management and microbial quality control in food and beverage production.

Molecular Diagnostics

Molecular diagnostics significantly impacts patient care and laboratory management, with rapid real-time PCR.

Sepsis and resistance testing

The threat of multi-drug resistance (MDR) among gram-negative and gram-positive pathogens has increased worldwide over recent years, impacting both hospital and community acquired infections. Bruker is addressing the need for rapid and accurate solutions to achieve fast identification and resistance detection from Positive Blood Cultures (PBC).